ESMINT 2019Editor's PickInterviewsEditors Pick HomepageNeuroEditors Pick NeuroNeuro InterviewsLatest news NeuroLearning AreasEvents ESMINT 2019: “Vast majority” of people do not expect children to have strokes
Editor's PickInterviewsEditors Pick HomepageNeuroEditors Pick NeuroNeuro InterviewsLatest news NeuroLearning AreasEventsSNIS 2019 SNIS 2019: “Almost unethical” not to broaden thrombectomy inclusion criteria and treat more patients
Editor's PickInterviewsEditors Pick HomepageSpinalLearning AreasEditors Pick SpinalSpinal InterviewsIMAST 2019 IMAST 2019: Industry sponsored disc replacement trials should be treated with “caution”
Editor's PickInterviewsEditors Pick HomepageNeuroEditors Pick NeuroNeuro InterviewsLearning AreasEventsSNIS 2019 SNIS 2019: Next-generation thrombectomy will be “even more powerful”
IRPeripheralEditors Pick PeripheralPeripheral InterviewsLatest news PeripheralVEITHsymposium 2018 PCSK9 inhibitors, rivaroxaban and a diabetes drug are major milestones in PAD treatment
